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Table 1
T-CELL GENE EXPRESSION (POST VS PRE-PRIMING)
Gene Effective CTLs (n¼5) Ineffective CTLs (n¼3)
Fold-change
(mean, SEM)
P-value Fold-change
(mean, SEM)
P-value
4-1BB 14 (7.7) 0.025 0.39 (0.22) 0.19
HVEM 7.3 (3.7) 0.028 1.57 (1.28) 0.95
LIGHT 17.3 (7.3) 0.016 1.1 (0.98) 0.44
PRKC-a 4.6 (1.1) 0.023 0.29 (0.08) 0.034
PRKC-q 13.7 (6.7) 0.01 0.99 (0.41) 0.71
LAIR1 16.2 (5.6) 0.003 17.15 (16.5) 0.60
PP2A 6.7 (2.6) 0.025 1.89 (1.52) 0.79
2B4 4.98 (1.82) 0.27 11.2 (0.9) 0.02
LTA-a 3.61 (2.11) 0.23 0.16 (0.02) 0.043
LTA-b 2.49 (0.99) 0.24 0.23 (0.08) 0.042
Figure 2. Cytotoxicity of CTLs primed against autologous AML blasts using IL-
15 and CD28ab
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compared to pre-priming (56% to 24%, p-value 0.046,
n¼4). [Fig 3]
6. T-cell co-signaling molecules’ gene expression differed
in effective vs ineffective CTLs. [Table 1]
Conclusions: (a) AML-speciﬁc auto CTLs can be generated (b)
Tregs decreased after priming in effective CTLs (c) Gene
expression of T-cell co-stimulatory markers differ notably in
effective & ineffective CTLs.
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Table 1
Gene Expression Proﬁle
RESISTANT VS NON-RESISTANT AML
Gene DD Ct (mean, SEM) 95% CI P-value Relative
fold change
JAK2 -5.38 (0.94) -7.67 -3.08 0.0012 41.52
S100A8 -7.16 (2.66) -14.01 -0.32 0.0432 143.27
S100A9 -8.31 (2.75) -15.04 -1.59 0.0233 318.37
c-myc -2.78 (0.59) -4.24 -1.33 0.0034 6.89
JAK1 -4.63 (1.98) -9.48 0.21 0.0579 24.83
JAK3 -5.90 (2.17) -12.81 1.01 0.0726 59.77
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Background: Ex-vivo expansion of CBT-cells using CD3/
CD28 co-stimulatory beads, IL-2 + IL-7 & subsequent priming
against leukemia cell lines using IL-15 generated speciﬁc
CTLs. [1, 2] Using similar immune-stimulatory culture con-
ditions, we generated auto PB-derived CTLs from AML pa-
tients in 5 of 8 samples. [Abstract #5836] The aim of present
study was to ﬁnd source of disparity between “resistant”
(n¼3) & non-resistant AML (n¼5).
Hypothesis: We hypothesized (a) in contrast to AML cells
that are susceptible to cytotoxicity by auto CTLs (n¼5), the
“resistant” AML cells (n¼3), would possess features similar to
myeloid-derived suppressor cells (MDSCs).
Methods: AML blasts were puriﬁed from PBMCs of AML
patients admitted with blast crisis (n¼8). AML-speciﬁc auto
CTLs were generated using immune-stimulatory culture
conditions as described. [Abstract #5836] RNA puriﬁcation &
RT-qPCR from blasts was done using Trizol reagent (Life
Technologies) & Power SYBR Green master mix (Applied
Biosystems) with StepOne Plus system (Life Technologies) as
suggested by manufacturers. Genes with deﬁned role in
MDSC generation [2] were selected for analysis. Primers
were designed using NCBI primer blast. [3] GAPDH was used
as house-keeping gene. Student t-test was used to compare
the groups.
Results: Resistant blasts had signiﬁcant up-regulation
of JAK-2, S100A8, S100A9 and c-myc compared to the
susceptible blasts. [Table 1] Although JAK-1 and JAK-3Figure 1. Signaling pathways involved in the expansion of mDSCs [2] (rwere up-regulated notably, statistical signiﬁcance was
not met.
Discussion: JAK-2 signaling pathway is critical for MDSC
generation and survival, which induces c-myc expression,
while S100A8 & S100A9 potentiate the suppressive effects of
MDSC. [Figure 1] [2] Many solid tumors assume MDSC-like
phenotype, [2] but this is rarely reported in hematological
malignancies. [3, 4] Our ﬁndings mandate further validation.
If replicated, therapeutic roles of JAK and S100 pathway in-
hibitors could be explored.
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